Subscribe To

Price Alert Latest News Economic Calendar News

BIOR / Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report financial results and provide a corporate update for the second quarter ended June 30, 2023. The company's management will host a webcast and conference call on Monday, August 14, 2023, after the close of financial markets at 4:30 PM Eastern time / 1:30 PM Pacific time. Read More

Demo Live Account See Partner Details

Content Topics

Biora

Therapeutics

Report

Second

Quarter

2023

Financial

Results

Provide

Corporate

Update

Stock

BIOR

Posted: Jul 15 2023, 02:22

Author Name: GlobeNewsWire

BIOR News

By Seeking Alpha
August 14, 2023

Biora Therapeutics, Inc. (BIOR) Q2 2023 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Chuck Padala - Managing Direc

By GlobeNewsWire
July 15, 2023

Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, to

By GlobeNewsWire
June 8, 2023

Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes

SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, to

By Seeking Alpha
May 15, 2023

Biora Therapeutics, Inc. (BIOR) Q1 2023 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Kristy Grabowski - IR Aditya Moh

By Seeking Alpha
March 30, 2023

Biora Therapeutics, Inc. (BIOR) Q4 2022 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Chuck Padala – Managing Dire

By InvestorPlace
January 11, 2023

Why Is Biora Therapeutics (BIOR) Stock Up 12% Today?

Biora Therapeutics (NASDAQ: BIOR ) stock is on the rise Wednesday following news of feedback from the FDA. Today's news concerns the company's Targete

By Schaeffers Research
January 11, 2023

Biora Therapeutics Stock Extend Surge on FDA Feedback

Biora Therapeutics Inc (NASDAQ:BIOR) is looking to extend yesterday's pop, last seen up 8.5% at $5.86.

By Seeking Alpha
November 14, 2022

Biora Therapeutics, Inc. (BIOR) Q3 2022 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Alexandra Schuman - IR, Life

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.